Save the date: 20th GBG Annual Meeting 2023
24.01.2023
The 20th GBG Annual Meeting 2023 will start 2nd to 3rd of March 2023 at the Steigenberger Airport Hotel
We are pleased to announce our 2-day, international GBG Annual Meeting in Presence again next year. In 2023, however, our scientific discourse on the topic of breast cancer will be held under a very special star: We celebrate our
20th GBG Annual Meeting
Physicians and scientists will inform about the current national and international study situation of the German Breast Group. In addition, experiences with international clinical trials and joint collaborations will be shared.
Knowledge can be deepened in specific workshops and one's own network can be cultivated in expert discussions on site. Outstanding keynote speakers round off our diverse scientific programme.
Put the date of the 20th Annual Meeting of the GBG in your calendar today and be there!
Where? Steigenberger Airport Hotel Frankfurt am Main
When? Thursday, 2 March to Friday, 3 March 2023
The event is hybrid, so virtual participation is also possible
News
-
28.02.2023 Annual Scientific Report 2022 published
Our Annual Scientific Report 2022 provides a concise overview of current study findings along with important lectures and research posters presented by our members from the last year.
Mehr ... -
23.01.2023 St.Gallen International Breast Cancer Conference 2023
The 18th St.Gallen International Breast Cancer Conference 2023 will take place from 15 – 18 March 2023 in Vienna / Austria as a hybrid conference, allowing both in-person and virtual access
Mehr ... -
18.11.2022 Desiree: dose escalation of everolimus published
We are proud to inform you that our article A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE; GBG 86) is now available online.
Mehr ... -
08.11.2022 GBG research at SABCS 2022
We are proud to present our research at the San Antonio Breast Cancer Symposium, December 6-10
Mehr ... -
14.10.2022 Location of Subcutaneous Trastuzumab Injection
Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: pharmacokinetic, safety and patients´ preference - substudy of the randomised phase III GAIN-2 study
Mehr ...